II Trademark

Trademark Overview

On Wednesday, March 1, 2023, a trademark application was filed for II with the United States Patent and Trademark Office. The USPTO has given the II trademark a serial number of 97817022. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, September 10, 2024. This trademark is owned by Novartis AG. The II trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Providing medical and health care information to improve understanding about dry eye disease and its treatment
ii

General Information

Serial Number97817022
Word MarkII
Filing DateWednesday, March 1, 2023
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, September 10, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 10, 2024

Trademark Statements

Pseudo MarkTWO; 2; I I
Goods and ServicesProviding medical and health care information to improve understanding about dry eye disease and its treatment

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, March 20, 2023
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBAUSCH + LOMB IRELAND LIMITED
Party Type20 - Owner at Publication
Legal Entity Type77 - NOT AVAILABLE
AddressDUBLIN D24PPT3
IE
Party NameBAUSCH + LOMB IRELAND LIMITED
Party Type11 - New Owner Before Publication
Legal Entity Type77 - NOT AVAILABLE
AddressDUBLIN D24PPT3
IE
Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBasel 4002
CH

Trademark Events

Event DateEvent Description
Saturday, March 4, 2023NEW APPLICATION ENTERED
Monday, March 20, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, October 25, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, October 25, 2023TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, October 25, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, October 25, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 1, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, November 30, 2023ASSIGNED TO EXAMINER
Tuesday, February 27, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Tuesday, February 27, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Monday, December 11, 2023NON-FINAL ACTION WRITTEN
Monday, December 11, 2023NON-FINAL ACTION E-MAILED
Monday, December 11, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, June 11, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 11, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 11, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, June 11, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 11, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, June 11, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, August 6, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 21, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 10, 2024PUBLISHED FOR OPPOSITION
Tuesday, September 10, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Related Keywords

understanding about disease treatment improve information medical health care providing